Tianjin Lisheng Pharmaceutical Co Ltd (002393) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.061x

Based on the latest financial reports, Tianjin Lisheng Pharmaceutical Co Ltd (002393) has a cash flow conversion efficiency ratio of 0.061x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥287.81 Million ≈ $42.12 Million USD) by net assets (CN¥4.69 Billion ≈ $686.81 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Tianjin Lisheng Pharmaceutical Co Ltd market capitalisation for the company's overall valuation and market capitalisation.

Tianjin Lisheng Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how Tianjin Lisheng Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Tianjin Lisheng Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tianjin Lisheng Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore Tianjin Lisheng Pharmaceutical Co Ltd cash earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
A&W Food Services of Canada TO:AW	0.063x
Cass Information Systems Inc NASDAQ:CASS	0.060x
Shenzhen Sinovatio Technology Co Ltd Class A SHE:002912	-0.022x
First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued NASDAQ:TRAXV	-0.126x
uPI Semiconductor Corp TW:6719	0.020x
Arena REIT AU:ARF	0.027x
Shenzhen Kaizhong Precision Technology Co Ltd SHE:002823	0.082x
Ningbo Marine Co Ltd SHG:600798	0.040x

Annual Cash Flow Conversion Efficiency for Tianjin Lisheng Pharmaceutical Co Ltd (2007–2025)

The table below shows the annual cash flow conversion efficiency of Tianjin Lisheng Pharmaceutical Co Ltd from 2007 to 2025. View Tianjin Lisheng Pharmaceutical Co Ltd stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥4.69 Billion ≈ $686.81 Million	CN¥451.85 Million ≈ $66.12 Million	0.096x	+423.55%
2024-12-31	CN¥4.80 Billion ≈ $702.39 Million	CN¥88.26 Million ≈ $12.92 Million	0.018x	-56.96%
2023-12-31	CN¥4.90 Billion ≈ $717.53 Million	CN¥209.51 Million ≈ $30.66 Million	0.043x	-43.92%
2022-12-31	CN¥4.35 Billion ≈ $636.45 Million	CN¥331.38 Million ≈ $48.49 Million	0.076x	+71.15%
2021-12-31	CN¥4.41 Billion ≈ $645.40 Million	CN¥196.34 Million ≈ $28.73 Million	0.045x	+150.77%
2020-12-31	CN¥4.30 Billion ≈ $629.53 Million	CN¥76.37 Million ≈ $11.18 Million	0.018x	-70.78%
2019-12-31	CN¥4.42 Billion ≈ $646.32 Million	CN¥268.33 Million ≈ $39.26 Million	0.061x	+19.96%
2018-12-31	CN¥3.21 Billion ≈ $470.07 Million	CN¥162.69 Million ≈ $23.81 Million	0.051x	-12.99%
2017-12-31	CN¥3.08 Billion ≈ $450.66 Million	CN¥179.25 Million ≈ $26.23 Million	0.058x	+1.09%
2016-12-31	CN¥3.02 Billion ≈ $441.21 Million	CN¥173.60 Million ≈ $25.40 Million	0.058x	-13.70%
2015-12-31	CN¥2.97 Billion ≈ $434.60 Million	CN¥198.13 Million ≈ $28.99 Million	0.067x	+168.73%
2014-12-31	CN¥2.91 Billion ≈ $425.81 Million	CN¥72.24 Million ≈ $10.57 Million	0.025x	-74.94%
2013-12-31	CN¥2.92 Billion ≈ $427.86 Million	CN¥289.62 Million ≈ $42.38 Million	0.099x	+10.09%
2012-12-31	CN¥2.79 Billion ≈ $407.77 Million	CN¥250.72 Million ≈ $36.69 Million	0.090x	+87.07%
2011-12-31	CN¥2.80 Billion ≈ $409.46 Million	CN¥134.58 Million ≈ $19.69 Million	0.048x	-31.68%
2010-12-31	CN¥2.65 Billion ≈ $387.79 Million	CN¥186.55 Million ≈ $27.30 Million	0.070x	-83.10%
2009-12-31	CN¥470.87 Million ≈ $68.90 Million	CN¥196.14 Million ≈ $28.70 Million	0.417x	+56.23%
2008-12-31	CN¥474.77 Million ≈ $69.47 Million	CN¥126.59 Million ≈ $18.52 Million	0.267x	-34.13%
2007-12-31	CN¥432.23 Million ≈ $63.25 Million	CN¥174.94 Million ≈ $25.60 Million	0.405x	--

About Tianjin Lisheng Pharmaceutical Co Ltd

SHE:002393 China Drug Manufacturers - Specialty & Generic

Market Cap

$613.09 Million

CN¥4.19 Billion CNY

Market Cap Rank

#11299 Global

#3165 in China

Share Price

CN¥13.59

Change (1 day)

+1.04%

52-Week Range

CN¥13.44 - CN¥24.25

All Time High

CN¥46.19